Reports

Industry Research Reports

Dry Powder Inhalation Excipients - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Dry Powder Inhalation Excipients - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-03-13

Pages: 127 Pages

Report ld: 4662235

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Dry Powder Inhalation Excipients Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

5.4%

marketSize

Market Size,2031

USD 2,491

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 1,817 million
Market Forecast in 2031(Value)
US$ 2,491 million
CAGR
5.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.

Dry powder inhalation excipients are auxiliary components used in dry powder inhalation formulations to improve drug dispersion, stability, and inhalation performance. They typically include lactose, mannitol, and other sugars, as well as certain inorganic salts. By optimizing the particle size and distribution of the drug, these excipients enhance the lung deposition rate and bioavailability of the drug. Dry powder inhalation excipients play a crucial role in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease, ensuring effective drug inhalation and therapeutic effects.

North American market for Dry Powder Inhalation Excipients was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dry Powder Inhalation Excipients was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Dry Powder Inhalation Excipients was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Dry Powder Inhalation Excipients include Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, Sheffield (Kerry), Armor Pharma, Abbott, Norvatis, Bayer, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Dry Powder Inhalation Excipients, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dry Powder Inhalation Excipients by region & country, by Type, and by Application.

The Dry Powder Inhalation Excipients market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Powder Inhalation Excipients.

MARKET SEGMENTATION

By Company

  • Protheragen-ING
  • DFE Pharma
  • Meggle-Pharma
  • Pfanstiehl
  • Merck
  • Sheffield (Kerry)
  • Armor Pharma
  • Abbott
  • Norvatis
  • Bayer
  • Jiangsu Daoning Drug

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Lactose
  • Magnesium Stearate
  • Others

Segment by Application

  • DPI
  • MDI
  • Nebulizer
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 2: Detailed analysis of Dry Powder Inhalation Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 5: Sales, revenue of Dry Powder Inhalation Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 6: Sales, revenue of Dry Powder Inhalation Excipients in country level. It provides sigmate data by Type, and by Application for each country/region.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Dry Powder Inhalation Excipients Product Introduction

1.2 Global Dry Powder Inhalation Excipients Market Size Forecast

1.2.1 Global Dry Powder Inhalation Excipients Sales Value (2020-2031)

1.2.2 Global Dry Powder Inhalation Excipients Sales Volume (2020-2031)

1.2.3 Global Dry Powder Inhalation Excipients Sales Price (2020-2031)

1.3 Dry Powder Inhalation Excipients Market Trends & Drivers

1.3.1 Dry Powder Inhalation Excipients Industry Trends

1.3.2 Dry Powder Inhalation Excipients Market Drivers & Opportunity

1.3.3 Dry Powder Inhalation Excipients Market Challenges

1.3.4 Dry Powder Inhalation Excipients Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Dry Powder Inhalation Excipients Players Revenue Ranking (2024)

2.2 Global Dry Powder Inhalation Excipients Revenue by Company (2020-2025)

2.3 Global Dry Powder Inhalation Excipients Players Sales Volume Ranking (2024)

2.4 Global Dry Powder Inhalation Excipients Sales Volume by Company Players (2020-2025)

2.5 Global Dry Powder Inhalation Excipients Average Price by Company (2020-2025)

2.6 Key Manufacturers Dry Powder Inhalation Excipients Manufacturing Base and Headquarters

2.7 Key Manufacturers Dry Powder Inhalation Excipients Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Dry Powder Inhalation Excipients

2.9 Dry Powder Inhalation Excipients Market Competitive Analysis

2.9.1 Dry Powder Inhalation Excipients Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Dry Powder Inhalation Excipients Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Powder Inhalation Excipients as of 2024)

2.10 Mergers & Acquisitions, Expansion

muLu

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Lactose

3.1.2 Magnesium Stearate

3.1.3 Others

3.2 Global Dry Powder Inhalation Excipients Sales Value by Type

3.2.1 Global Dry Powder Inhalation Excipients Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Dry Powder Inhalation Excipients Sales Value, by Type (2020-2031)

3.2.3 Global Dry Powder Inhalation Excipients Sales Value, by Type (%) (2020-2031)

3.3 Global Dry Powder Inhalation Excipients Sales Volume by Type

3.3.1 Global Dry Powder Inhalation Excipients Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Dry Powder Inhalation Excipients Sales Volume, by Type (2020-2031)

3.3.3 Global Dry Powder Inhalation Excipients Sales Volume, by Type (%) (2020-2031)

3.4 Global Dry Powder Inhalation Excipients Average Price by Type (2020-2031)

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 DPI

4.1.2 MDI

4.1.3 Nebulizer

4.1.4 Others

4.2 Global Dry Powder Inhalation Excipients Sales Value by Application

4.2.1 Global Dry Powder Inhalation Excipients Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Dry Powder Inhalation Excipients Sales Value, by Application (2020-2031)

4.2.3 Global Dry Powder Inhalation Excipients Sales Value, by Application (%) (2020-2031)

4.3 Global Dry Powder Inhalation Excipients Sales Volume by Application

4.3.1 Global Dry Powder Inhalation Excipients Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Dry Powder Inhalation Excipients Sales Volume, by Application (2020-2031)

4.3.3 Global Dry Powder Inhalation Excipients Sales Volume, by Application (%) (2020-2031)

4.4 Global Dry Powder Inhalation Excipients Average Price by Application (2020-2031)

muLu

5 Segmentation by Region

5.1 Global Dry Powder Inhalation Excipients Sales Value by Region

5.1.1 Global Dry Powder Inhalation Excipients Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Dry Powder Inhalation Excipients Sales Value by Region (2020-2025)

5.1.3 Global Dry Powder Inhalation Excipients Sales Value by Region (2026-2031)

5.1.4 Global Dry Powder Inhalation Excipients Sales Value by Region (%), (2020-2031)

5.2 Global Dry Powder Inhalation Excipients Sales Volume by Region

5.2.1 Global Dry Powder Inhalation Excipients Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Dry Powder Inhalation Excipients Sales Volume by Region (2020-2025)

5.2.3 Global Dry Powder Inhalation Excipients Sales Volume by Region (2026-2031)

5.2.4 Global Dry Powder Inhalation Excipients Sales Volume by Region (%), (2020-2031)

5.3 Global Dry Powder Inhalation Excipients Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Dry Powder Inhalation Excipients Sales Value, 2020-2031

5.4.2 North America Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Dry Powder Inhalation Excipients Sales Value, 2020-2031

5.5.2 Europe Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Dry Powder Inhalation Excipients Sales Value, 2020-2031

5.6.2 Asia Pacific Dry Powder Inhalation Excipients Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Dry Powder Inhalation Excipients Sales Value, 2020-2031

5.7.2 South America Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Dry Powder Inhalation Excipients Sales Value, 2020-2031

5.8.2 Middle East & Africa Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Dry Powder Inhalation Excipients Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Dry Powder Inhalation Excipients Sales Value and Sales Volume

6.2.1 Key Countries/Regions Dry Powder Inhalation Excipients Sales Value, 2020-2031

6.2.2 Key Countries/Regions Dry Powder Inhalation Excipients Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Dry Powder Inhalation Excipients Sales Value, 2020-2031

6.3.2 United States Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Dry Powder Inhalation Excipients Sales Value, 2020-2031

6.4.2 Europe Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Dry Powder Inhalation Excipients Sales Value, 2020-2031

6.5.2 China Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031

6.5.3 China Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Dry Powder Inhalation Excipients Sales Value, 2020-2031

6.6.2 Japan Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Dry Powder Inhalation Excipients Sales Value, 2020-2031

6.7.2 South Korea Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Dry Powder Inhalation Excipients Sales Value, 2020-2031

6.8.2 Southeast Asia Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Dry Powder Inhalation Excipients Sales Value, 2020-2031

6.9.2 India Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031

6.9.3 India Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031

muLu

7 Company Profiles

7.1 Protheragen-ING

7.1.1 Protheragen-ING Company Information

7.1.2 Protheragen-ING Introduction and Business Overview

7.1.3 Protheragen-ING Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Protheragen-ING Dry Powder Inhalation Excipients Product Offerings

7.1.5 Protheragen-ING Recent Development

7.2 DFE Pharma

7.2.1 DFE Pharma Company Information

7.2.2 DFE Pharma Introduction and Business Overview

7.2.3 DFE Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 DFE Pharma Dry Powder Inhalation Excipients Product Offerings

7.2.5 DFE Pharma Recent Development

7.3 Meggle-Pharma

7.3.1 Meggle-Pharma Company Information

7.3.2 Meggle-Pharma Introduction and Business Overview

7.3.3 Meggle-Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Meggle-Pharma Dry Powder Inhalation Excipients Product Offerings

7.3.5 Meggle-Pharma Recent Development

7.4 Pfanstiehl

7.4.1 Pfanstiehl Company Information

7.4.2 Pfanstiehl Introduction and Business Overview

7.4.3 Pfanstiehl Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Pfanstiehl Dry Powder Inhalation Excipients Product Offerings

7.4.5 Pfanstiehl Recent Development

7.5 Merck

7.5.1 Merck Company Information

7.5.2 Merck Introduction and Business Overview

7.5.3 Merck Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Merck Dry Powder Inhalation Excipients Product Offerings

7.5.5 Merck Recent Development

7.6 Sheffield (Kerry)

7.6.1 Sheffield (Kerry) Company Information

7.6.2 Sheffield (Kerry) Introduction and Business Overview

7.6.3 Sheffield (Kerry) Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Sheffield (Kerry) Dry Powder Inhalation Excipients Product Offerings

7.6.5 Sheffield (Kerry) Recent Development

7.7 Armor Pharma

7.7.1 Armor Pharma Company Information

7.7.2 Armor Pharma Introduction and Business Overview

7.7.3 Armor Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Armor Pharma Dry Powder Inhalation Excipients Product Offerings

7.7.5 Armor Pharma Recent Development

7.8 Abbott

7.8.1 Abbott Company Information

7.8.2 Abbott Introduction and Business Overview

7.8.3 Abbott Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Abbott Dry Powder Inhalation Excipients Product Offerings

7.8.5 Abbott Recent Development

7.9 Norvatis

7.9.1 Norvatis Company Information

7.9.2 Norvatis Introduction and Business Overview

7.9.3 Norvatis Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Norvatis Dry Powder Inhalation Excipients Product Offerings

7.9.5 Norvatis Recent Development

7.10 Bayer

7.10.1 Bayer Company Information

7.10.2 Bayer Introduction and Business Overview

7.10.3 Bayer Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Bayer Dry Powder Inhalation Excipients Product Offerings

7.10.5 Bayer Recent Development

7.11 Jiangsu Daoning Drug

7.11.1 Jiangsu Daoning Drug Company Information

7.11.2 Jiangsu Daoning Drug Introduction and Business Overview

7.11.3 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product Offerings

7.11.5 Jiangsu Daoning Drug Recent Development

muLu

8 Industry Chain Analysis

8.1 Dry Powder Inhalation Excipients Industrial Chain

8.2 Dry Powder Inhalation Excipients Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Dry Powder Inhalation Excipients Sales Model

8.5.2 Sales Channel

8.5.3 Dry Powder Inhalation Excipients Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Dry Powder Inhalation Excipients Market Trends
Table 2. Dry Powder Inhalation Excipients Market Drivers & Opportunity
Table 3. Dry Powder Inhalation Excipients Market Challenges
Table 4. Dry Powder Inhalation Excipients Market Restraints
Table 5. Global Dry Powder Inhalation Excipients Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Dry Powder Inhalation Excipients Revenue Market Share by Company (2020-2025)
Table 7. Global Dry Powder Inhalation Excipients Sales Volume by Company (2020-2025) & (Tons)
Table 8. Global Dry Powder Inhalation Excipients Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Dry Powder Inhalation Excipients Price by Company (2020-2025) & (US$/Ton)
Table 10. Key Manufacturers Dry Powder Inhalation Excipients Manufacturing Base and Headquarters
Table 11. Key Manufacturers Dry Powder Inhalation Excipients Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Dry Powder Inhalation Excipients
Table 13. Global Dry Powder Inhalation Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Powder Inhalation Excipients as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Dry Powder Inhalation Excipients Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Dry Powder Inhalation Excipients Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Dry Powder Inhalation Excipients Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Dry Powder Inhalation Excipients Sales Market Share in Value by Type (2020-2025)
Table 20. Global Dry Powder Inhalation Excipients Sales Market Share in Value by Type (2026-2031)
Table 21. Global Dry Powder Inhalation Excipients Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Dry Powder Inhalation Excipients Sales Volume by Type (2020-2025) & (Tons)
Table 23. Global Dry Powder Inhalation Excipients Sales Volume by Type (2026-2031) & (Tons)
Table 24. Global Dry Powder Inhalation Excipients Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Dry Powder Inhalation Excipients Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Dry Powder Inhalation Excipients Price by Type (2020-2025) & (US$/Ton)
Table 27. Global Dry Powder Inhalation Excipients Price by Type (2026-2031) & (US$/Ton)
Table 28. Global Dry Powder Inhalation Excipients Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Dry Powder Inhalation Excipients Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Dry Powder Inhalation Excipients Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Dry Powder Inhalation Excipients Sales Market Share in Value by Application (2020-2025)
Table 32. Global Dry Powder Inhalation Excipients Sales Market Share in Value by Application (2026-2031)
Table 33. Global Dry Powder Inhalation Excipients Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
Table 34. Global Dry Powder Inhalation Excipients Sales Volume by Application (2020-2025) & (Tons)
Table 35. Global Dry Powder Inhalation Excipients Sales Volume by Application (2026-2031) & (Tons)
Table 36. Global Dry Powder Inhalation Excipients Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Dry Powder Inhalation Excipients Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Dry Powder Inhalation Excipients Price by Application (2020-2025) & (US$/Ton)
Table 39. Global Dry Powder Inhalation Excipients Price by Application (2026-2031) & (US$/Ton)
Table 40. Global Dry Powder Inhalation Excipients Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Dry Powder Inhalation Excipients Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Dry Powder Inhalation Excipients Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Dry Powder Inhalation Excipients Sales Value by Region (2020-2025) & (%)
Table 44. Global Dry Powder Inhalation Excipients Sales Value by Region (2026-2031) & (%)
Table 45. Global Dry Powder Inhalation Excipients Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
Table 46. Global Dry Powder Inhalation Excipients Sales Volume by Region (2020-2025) & (Tons)
Table 47. Global Dry Powder Inhalation Excipients Sales Volume by Region (2026-2031) & (Tons)
Table 48. Global Dry Powder Inhalation Excipients Sales Volume by Region (2020-2025) & (%)
Table 49. Global Dry Powder Inhalation Excipients Sales Volume by Region (2026-2031) & (%)
Table 50. Global Dry Powder Inhalation Excipients Average Price by Region (2020-2025) & (US$/Ton)
Table 51. Global Dry Powder Inhalation Excipients Average Price by Region (2026-2031) & (US$/Ton)
Table 52. Key Countries/Regions Dry Powder Inhalation Excipients Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Dry Powder Inhalation Excipients Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Dry Powder Inhalation Excipients Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Dry Powder Inhalation Excipients Sales Volume, (2020-2025) & (Tons)
Table 56. Key Countries/Regions Dry Powder Inhalation Excipients Sales Volume, (2026-2031) & (Tons)
Table 57. Protheragen-ING Company Information
Table 58. Protheragen-ING Introduction and Business Overview
Table 59. Protheragen-ING Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 60. Protheragen-ING Dry Powder Inhalation Excipients Product Offerings
Table 61. Protheragen-ING Recent Development
Table 62. DFE Pharma Company Information
Table 63. DFE Pharma Introduction and Business Overview
Table 64. DFE Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 65. DFE Pharma Dry Powder Inhalation Excipients Product Offerings
Table 66. DFE Pharma Recent Development
Table 67. Meggle-Pharma Company Information
Table 68. Meggle-Pharma Introduction and Business Overview
Table 69. Meggle-Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 70. Meggle-Pharma Dry Powder Inhalation Excipients Product Offerings
Table 71. Meggle-Pharma Recent Development
Table 72. Pfanstiehl Company Information
Table 73. Pfanstiehl Introduction and Business Overview
Table 74. Pfanstiehl Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Pfanstiehl Dry Powder Inhalation Excipients Product Offerings
Table 76. Pfanstiehl Recent Development
Table 77. Merck Company Information
Table 78. Merck Introduction and Business Overview
Table 79. Merck Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Merck Dry Powder Inhalation Excipients Product Offerings
Table 81. Merck Recent Development
Table 82. Sheffield (Kerry) Company Information
Table 83. Sheffield (Kerry) Introduction and Business Overview
Table 84. Sheffield (Kerry) Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Sheffield (Kerry) Dry Powder Inhalation Excipients Product Offerings
Table 86. Sheffield (Kerry) Recent Development
Table 87. Armor Pharma Company Information
Table 88. Armor Pharma Introduction and Business Overview
Table 89. Armor Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Armor Pharma Dry Powder Inhalation Excipients Product Offerings
Table 91. Armor Pharma Recent Development
Table 92. Abbott Company Information
Table 93. Abbott Introduction and Business Overview
Table 94. Abbott Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Abbott Dry Powder Inhalation Excipients Product Offerings
Table 96. Abbott Recent Development
Table 97. Norvatis Company Information
Table 98. Norvatis Introduction and Business Overview
Table 99. Norvatis Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Norvatis Dry Powder Inhalation Excipients Product Offerings
Table 101. Norvatis Recent Development
Table 102. Bayer Company Information
Table 103. Bayer Introduction and Business Overview
Table 104. Bayer Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Bayer Dry Powder Inhalation Excipients Product Offerings
Table 106. Bayer Recent Development
Table 107. Jiangsu Daoning Drug Company Information
Table 108. Jiangsu Daoning Drug Introduction and Business Overview
Table 109. Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product Offerings
Table 111. Jiangsu Daoning Drug Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Dry Powder Inhalation Excipients Downstream Customers
Table 115. Dry Powder Inhalation Excipients Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Dry Powder Inhalation Excipients Product Picture
Figure 2. Global Dry Powder Inhalation Excipients Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Dry Powder Inhalation Excipients Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Dry Powder Inhalation Excipients Sales Volume (2020-2031) & (Tons)
Figure 5. Global Dry Powder Inhalation Excipients Sales Price (2020-2031) & (US$/Ton)
Figure 6. Dry Powder Inhalation Excipients Report Years Considered
Figure 7. Global Dry Powder Inhalation Excipients Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Dry Powder Inhalation Excipients Players Sales Volume Ranking (2024) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dry Powder Inhalation Excipients Revenue in 2024
Figure 10. Dry Powder Inhalation Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Lactose Picture
Figure 12. Magnesium Stearate Picture
Figure 13. Others Picture
Figure 14. Global Dry Powder Inhalation Excipients Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Dry Powder Inhalation Excipients Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Dry Powder Inhalation Excipients Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
Figure 17. Global Dry Powder Inhalation Excipients Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Dry Powder Inhalation Excipients Price by Type (2020-2031) & (US$/Ton)
Figure 19. Product Picture of DPI
Figure 20. Product Picture of MDI
Figure 21. Product Picture of Nebulizer
Figure 22. Product Picture of Others
Figure 23. Global Dry Powder Inhalation Excipients Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 24. Global Dry Powder Inhalation Excipients Sales Value Market Share by Application, 2024 & 2031
Figure 25. Global Dry Powder Inhalation Excipients Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
Figure 26. Global Dry Powder Inhalation Excipients Sales Volume Market Share by Application, 2024 & 2031
Figure 27. Global Dry Powder Inhalation Excipients Price by Application (2020-2031) & (US$/Ton)
Figure 28. North America Dry Powder Inhalation Excipients Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Dry Powder Inhalation Excipients Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Dry Powder Inhalation Excipients Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Dry Powder Inhalation Excipients Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Dry Powder Inhalation Excipients Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Dry Powder Inhalation Excipients Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Dry Powder Inhalation Excipients Sales Value (%), (2020-2031)
Figure 39. Key Countries/Regions Dry Powder Inhalation Excipients Sales Volume (%), (2020-2031)
Figure 40. United States Dry Powder Inhalation Excipients Sales Value, (2020-2031) & (US$ Million)
Figure 41. United States Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
Figure 42. United States Dry Powder Inhalation Excipients Sales Value by Application (%), 2024 VS 2031
Figure 43. Europe Dry Powder Inhalation Excipients Sales Value, (2020-2031) & (US$ Million)
Figure 44. Europe Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
Figure 45. Europe Dry Powder Inhalation Excipients Sales Value by Application (%), 2024 VS 2031
Figure 46. China Dry Powder Inhalation Excipients Sales Value, (2020-2031) & (US$ Million)
Figure 47. China Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
Figure 48. China Dry Powder Inhalation Excipients Sales Value by Application (%), 2024 VS 2031
Figure 49. Japan Dry Powder Inhalation Excipients Sales Value, (2020-2031) & (US$ Million)
Figure 50. Japan Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
Figure 51. Japan Dry Powder Inhalation Excipients Sales Value by Application (%), 2024 VS 2031
Figure 52. South Korea Dry Powder Inhalation Excipients Sales Value, (2020-2031) & (US$ Million)
Figure 53. South Korea Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
Figure 54. South Korea Dry Powder Inhalation Excipients Sales Value by Application (%), 2024 VS 2031
Figure 55. Southeast Asia Dry Powder Inhalation Excipients Sales Value, (2020-2031) & (US$ Million)
Figure 56. Southeast Asia Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
Figure 57. Southeast Asia Dry Powder Inhalation Excipients Sales Value by Application (%), 2024 VS 2031
Figure 58. India Dry Powder Inhalation Excipients Sales Value, (2020-2031) & (US$ Million)
Figure 59. India Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
Figure 60. India Dry Powder Inhalation Excipients Sales Value by Application (%), 2024 VS 2031
Figure 61. Dry Powder Inhalation Excipients Industrial Chain
Figure 62. Dry Powder Inhalation Excipients Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Dry Powder Inhalation Excipients in 2025?zhanKai
The global market size of Dry Powder Inhalation Excipients in 2025 was 1817 Million USD.
What is the annual compound growth rate of the global Dry Powder Inhalation Excipients market size from 2025 to 2031?shouQi
What was the global market size of Dry Powder Inhalation Excipients in 2031?shouQi
Which region is expected to have the highest market share?shouQi
Which companies rank high in the global Dry Powder Inhalation Excipients market?shouQi
den_biaoTiZhungShi

Related Reports

Dry Powder Inhalation Excipients - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-03-13

Pages: 127 Pages

Report ld: 4662235

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

MARKET SEGMENTATION

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now